Edition:
United States

Aquinox Pharmaceuticals Inc (AQXP.OQ)

AQXP.OQ on NASDAQ Stock Exchange Global Market

2.24USD
13 Nov 2018
Change (% chg)

$-0.02 (-0.88%)
Prev Close
$2.26
Open
$2.26
Day's High
$2.31
Day's Low
$2.23
Volume
15,403
Avg. Vol
75,158
52-wk High
$16.85
52-wk Low
$1.98

Select another date:

Wed, Jun 27 2018

Aquinox to stop development of lead drug; shares plunge

Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much as 85 percent.

UPDATE 2-Aquinox to stop development of lead drug; shares plunge

June 27 Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much as 85 percent.

Aquinox Pharma's bladder pain drug fails to meet study goal

June 27 Aquinox Pharmaceuticals Inc said on Wednesday its treatment for bladder pain syndrome failed to meet the main goal of a late-stage trial, and the company plans to stop developing the drug.

Select another date: